Aspire Biopharma Holdings, Inc. (ASBP) Stock Overview
Explore Aspire Biopharma Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Aspire Biopharma Holdings, Inc. (ASBP)
Key Financials
Key Financials
Market Cap
842.2K
P/E Ratio
-0.94
EPS (TTM)
$-23.80
ROE
19.93%
ASBP Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Aspire Biopharma Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ASBP on the NASDAQ shows an RSI of 38.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.77 for the NASDAQ listing.
Key metrics behind Aspire Biopharma Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.94 and a market capitalization of 842.2K. Combined with our AI analysis, these give both institutional and retail investors a clear view of ASBP on the NASDAQ.